BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24962803)

  • 1. Orally active-targeted drug delivery systems for proteins and peptides.
    Li X; Yu M; Fan W; Gan Y; Hovgaard L; Yang M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1435-47. PubMed ID: 24962803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives.
    Reis CP; Silva C; Martinho N; Rosado C
    Ther Deliv; 2013 Feb; 4(2):251-65. PubMed ID: 23343163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches towards enhanced transepithelial drug delivery.
    Majumdar S; Mitra AK
    Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral delivery of peptides and proteins using lipid-based drug delivery systems.
    Li P; Nielsen HM; Müllertz A
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1289-304. PubMed ID: 22897647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water-in-oil microemulsions for effective transdermal delivery of proteins.
    Russell-Jones G; Himes R
    Expert Opin Drug Deliv; 2011 Apr; 8(4):537-46. PubMed ID: 21413905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of therapeutic proteins and peptides: a review on recent developments.
    Gupta S; Jain A; Chakraborty M; Sahni JK; Ali J; Dang S
    Drug Deliv; 2013 Aug; 20(6):237-46. PubMed ID: 23869787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
    Lehr CM
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral peptide and protein delivery: intestinal obstacles and commercial prospects.
    Smart AL; Gaisford S; Basit AW
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1323-35. PubMed ID: 24816134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral drug delivery systems using chemical conjugates or physical complexes.
    Al-Hilal TA; Alam F; Byun Y
    Adv Drug Deliv Rev; 2013 Jun; 65(6):845-64. PubMed ID: 23220326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Models to predict intestinal absorption of therapeutic peptides and proteins.
    Antunes F; Andrade F; Ferreira D; Nielsen HM; Sarmento B
    Curr Drug Metab; 2013 Jan; 14(1):4-20. PubMed ID: 21933113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the oral route possible for peptide and protein drug delivery?
    Morishita M; Peppas NA
    Drug Discov Today; 2006 Oct; 11(19-20):905-10. PubMed ID: 16997140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral films as breakthrough tools for oral delivery of proteins/peptides.
    Castro PM; Fonte P; Sousa F; Madureira AR; Sarmento B; Pintado ME
    J Control Release; 2015 Aug; 211():63-73. PubMed ID: 25979328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral colon delivery of insulin with the aid of functional adjuvants.
    Maroni A; Zema L; Del Curto MD; Foppoli A; Gazzaniga A
    Adv Drug Deliv Rev; 2012 May; 64(6):540-56. PubMed ID: 22086142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
    Soares AF; Carvalho Rde A; Veiga F
    Nanomedicine (Lond); 2007 Apr; 2(2):183-202. PubMed ID: 17716120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in cell-penetrating, non-peptide molecular carriers.
    Chung SK; Maiti KK; Lee WS
    Int J Pharm; 2008 Apr; 354(1-2):16-22. PubMed ID: 17890027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.
    Yadav SC; Kumari A; Yadav R
    Peptides; 2011 Jan; 32(1):173-87. PubMed ID: 20934475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery systems based on sugar-macromolecule conjugates.
    Davis BG; Robinson MA
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):279-88. PubMed ID: 11926134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The colon as a possible target for orally administered peptide and protein drugs.
    Haupt S; Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 2002; 19(6):499-551. PubMed ID: 12822734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.